Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis Panel, SBIR Topic 216 Phase I/II “Fast Track Development of Inhibitory Reagents for the Study of Protein Function”.
Date: March 28, 2006.
Time: 10:30 a.m. to 1 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, Executive Plaza North, 6130 Executive Boulevard, Conference Room J, Rockville, MD 20892, (Telephone Conference Call).
Contact Person: Gerald G. Lovinger, PhD., Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8101, Bethesda, MD 20892-8329, (301) 496-7987, email@example.com.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)Start Signature
Dated: February 21, 2006.
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1879 Filed 2-28-06; 8:45 am]
BILLING CODE 4140-01-M